Click on thumbnail to view the full-size ad on AdPharm

Introducing Simponi.
The first monthly SC anti TNF a…

… all in one

-Proven efficacy in RA, As and PsA
-SmartJect autoinjector – designed to be patient-friendly
-Low injection volume (0.5 mL)
-Human lgG1k monoclonal antibody
-Patient support through the BioAdvantage Network

Monthly Simponi

The Simponi SmartJect autoinjector. Designed to be arthritis-patient-friendly.

Brand name: Simponi
Generic name/category: Golimumab, Monoclonal antibodies, TNF-alpha inhibitors
Company: Schering-Plough
Country/Market: Canada, North America
Indication(s)/use: Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA) and Ankylosing Spondilitis (AS)
Target: Healthcare Professionals (HCP)
Tagline: all in one
Medium: Print ad
Size/duration: three-page spread
Publication/Aired: NEJM – September 24, 2009

To see all of this brand’s ads on AdPharm, click here

No! associated weight gain.
No! hormones.
No! waiting – rapid return to fertility.

Why more of your patients say yeas to ParaGard for their birth control

The time is right to make highly effective, nonhormonal ParaGard part of every contraceptive conversation.

Brand name: ParaGard
Generic name/category: copper-containing intrauterine contraceptive (IUD)
Company: Duramed Pharmaceuticals
Country/Market: USA, North America
Indication(s)/use: contraception, birth control
Target: Healthcare Professionals (HCP)
Tagline: Fits her life like a “T”
Publication: Contemporary ob/gyn June 2009

Deliver the efficacy of a midpotent corticosteroid without the associated long-term risks

There was no statistically significant difference in efficacy as measured by SCORAD between EpiCeram Emulsion and fluticasone propionate 0.05% cream at day 28.

Brand name: EpiCeram
Generic name/category: Skin Barrier Emulsion
Company: Promius Pharma
Country/Market: USA, North America
Indication(s)/use: Dry skin conditions, relief and management of burning and itching associated with various types of dermatoses
Target: Healthcare Professionals (HCP)
Tagline: Deliver the efficacy of a midpotent corticosteroid without the associated long-term risks
Publication: Dermatology Times May 2009

More dermatology products ads on AdPharm